Geode Capital Management
CMRA

Geode Capital Management’s Comera Life Sciences Holdings, Inc. Common Stock CMRA Stock Holding History

Geode Capital Management’s Portfolio CMRA Stock Details CMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-70,212
Closed -$22.4K – 4756
2023
Q3 		$22.4K Buy
70,212
+10,204
+17% +$5.38K ﹤0.01% 4601
2023
Q2 		$29.2K Hold
60,008
– – ﹤0.01% 4601
2023
Q1 		$53.9K Hold
60,008
– – ﹤0.01% 4499
2022
Q4 		$73K Buy
60,008
+11,858
+25% +$17.3K ﹤0.01% 4497
2022
Q3 		$77K Buy
+48,150
New +$115K ﹤0.01% 4668

Geode Capital Management's CMRA Position: Q4 2023 in Review

Geode Capital Management sold out of Comera Life Sciences Holdings, Inc. Common Stock (CMRA) in Q4 2023, closing a stake of 70,212 shares — an estimated $22.4K sold.

Geode Capital Management first reported a position in CMRA in Q3 2022 and held it in 5 quarters. The position peaked at $77K in Q3 2022. 0 funds tracked by Wall St. Rank hold CMRA as of Q4 2023.

  • Geode Capital Management reported no remaining Comera Life Sciences Holdings, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Geode Capital Management sold 70,212 Comera Life Sciences Holdings, Inc. Common Stock shares in Q4 2023, an estimated $22.4K.
  • Geode Capital Management first reported a position in Comera Life Sciences Holdings, Inc. Common Stock in Q3 2022 and held it in 5 quarters.
  • Geode Capital Management's Comera Life Sciences Holdings, Inc. Common Stock position peaked at $77K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Comera Life Sciences Holdings, Inc. Common Stock as of Q4 2023.

Based on Geode Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.